BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1346499)

  • 1. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.
    Guillevin L; Fain O; Lhote F; Jarrousse B; Le Thi Huong D; Bussel A; Leon A
    Arthritis Rheum; 1992 Feb; 35(2):208-15. PubMed ID: 1346499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.
    Guillevin L; Lhote F; Cohen P; Jarrousse B; Lortholary O; Généreau T; Léon A; Bussel A
    Arthritis Rheum; 1995 Nov; 38(11):1638-45. PubMed ID: 7488285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.
    Guillevin L; Jarrousse B; Lok C; Lhote F; Jais JP; Le Thi Huong Du D; Bussel A
    J Rheumatol; 1991 Apr; 18(4):567-74. PubMed ID: 1676753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: indications of plasma exchanges.
    Guillevin L; Lhote F
    Transfus Sci; 1994 Dec; 15(4):371-88. PubMed ID: 10155556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A meta-analysis of 3 prospective controlled trials including 182 patients over 12 years.
    Guillevin L; Lhote F; Jarrousse B; Fain O
    Ann Med Interne (Paris); 1992; 143(6):405-16. PubMed ID: 1363508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
    Guillevin L; Lhote F; Gayraud M; Cohen P; Jarrousse B; Lortholary O; Thibult N; Casassus P
    Medicine (Baltimore); 1996 Jan; 75(1):17-28. PubMed ID: 8569467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of polyarteritis nodosa and Churg-Strauss angiitis: indications of plasma exchange. Results of three prospective trials in 162 patients. The Cooperative Study Group for the Study of Polyarteritis Nodosa.
    Guillevin L
    Prog Clin Biol Res; 1990; 337():309-17. PubMed ID: 1972283
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal tract involvement in polyarteritis nodosa and Churg-Strauss syndrome.
    Guillevin L; Lhote F; Gallais V; Jarrousse B; Royer I; Gayraud M; Benichou J
    Ann Med Interne (Paris); 1995; 146(4):260-7. PubMed ID: 7653948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients.
    Bourgarit A; Toumelin PL; Pagnoux C; Cohen P; Mahr A; Guern VL; Mouthon L; Guillevin L;
    Medicine (Baltimore); 2005 Sep; 84(5):323-330. PubMed ID: 16148732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyarteritis nodosa and Churg-Strauss syndrome. An internist's view.
    Guillevin L; Gayraud M; Casassus P
    Adv Exp Med Biol; 1993; 336():173-84. PubMed ID: 7905230
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
    Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
    Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides.
    Gayraud M; Guillevin L; Cohen P; Lhote F; Cacoub P; Deblois P; Godeau B; Ruel M; Vidal E; Piontud M; Ducroix JP; Lassoued S; Christoforov B; Babinet P
    Br J Rheumatol; 1997 Dec; 36(12):1290-7. PubMed ID: 9448590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of plasma exchange in the treatment of polyarteritis nodosa and Churg-Strauss angiitis and the contribution of adjuvant immunosuppressive therapy: a randomized trial in 72 patients.
    Lhote F; Guillevin L; Leon A; Bussel A; Lok C; Sobel A; Simon P
    Artif Organs; 1988 Feb; 12(1):27-33. PubMed ID: 2895628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cyclophosphamide in treatment of polyarteritis nodosa?
    Conn DL
    J Rheumatol; 1991 Apr; 18(4):489-90. PubMed ID: 1676751
    [No Abstract]   [Full Text] [Related]  

  • 15. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.
    Guillevin L; Cohen P; Gayraud M; Lhote F; Jarrousse B; Casassus P
    Medicine (Baltimore); 1999 Jan; 78(1):26-37. PubMed ID: 9990352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
    Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
    Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
    Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
    Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
    Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.
    Guillevin L; Lhote F; Leon A; Fauvelle F; Vivitski L; Trepo C
    J Rheumatol; 1993 Feb; 20(2):289-98. PubMed ID: 8097249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.
    Semple D; Keogh J; Forni L; Venn R
    Crit Care; 2005 Apr; 9(2):193-7. PubMed ID: 15774077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.